North America Ophthalmology Market Trends

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Ophthalmology Market Trends

  • Medical Devices
  • Published Report
  • Nov 2024
  • North America
  • 350 Pages
  • No of Tables: 211
  • No of Figures: 38

“The Growing Adoption of Telemedicine and AI-Powered Diagnostic tools”

The North America ophthalmology market is the growing adoption of telemedicine and AI-powered diagnostic tools. These innovations are transforming the way eye care is delivered by enabling remote consultations and screenings, which increases accessibility, especially in underserved and rural areas. AI technologies, including machine learning algorithms, are being used to analyze retinal images, detect early signs of conditions like diabetic retinopathy, glaucoma, and macular degeneration, and provide faster, more accurate diagnoses. Telemedicine platforms allow patients to connect with ophthalmologists for follow-up consultations, reducing the need for in-person visits and making eye care more convenient and efficient. This trend is not only improving patient access to timely treatments but also enhancing the overall efficiency of healthcare systems, making it a key driver of market growth in the ophthalmology sector. As a result, the integration of these technologies is expected to continue expanding, particularly in emerging markets, where healthcare infrastructure is still developing.

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 NORTH AMERICA OPHTHALMOLOGY MARKET : REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF EYE DISEASES

6.1.2 FOCUS ON PREVENTATIVE EYE CARE

6.1.3 GOVERNMENT EYECARE INITIATIVES

6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES

6.2 RESTRAINTS

6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES

6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS

6.3 OPPORTUNITIES

6.3.1 RISE IN THE AGING POPULATION

6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS

6.3.3 ENHANCED PATIENT EDUCATION

6.4 CHALLENGES

6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS

6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS

7 NORTH AMERICA OPHTHALMOLOGY MARKETNORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS

7.1 OVERVIEW

7.2 DEVICE

7.2.1 SURGICAL DEVICE

7.2.1.1 CATARACT SURGICAL DEVICES

7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

7.2.1.2.1 PHACOEMULSIFICATION DEVICES

7.2.1.2.2 CATARACT SURGICAL LASERS

7.2.1.2.3 IOL INJECTORS

7.2.1.3 VITREORETINAL SURGICAL DEVICES

7.2.1.3.1 VITREORETINAL PACKS

7.2.1.3.2 VITRECTOMY MACHINES

7.2.1.3.3 VITRECTOMY PROBES

7.2.1.3.4 PHOTOCOAGULATION LASERS

7.2.1.3.5 ILLUMINATION DEVICES

7.2.1.4 REFRACTIVE SURGICAL DEVICES

7.2.1.4.1 FEMTOSECOND LASERS

7.2.1.4.2 EXCIMER LASERS

7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

7.2.1.5 GLAUCOMA SURGICAL DEVICES

7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

7.2.1.5.2 GLAUCOMA LASER SYSTEMS

7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

7.2.2 DIAGNOSTIC DEVICE

7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS

7.2.2.2 AUTOREFRACTORS & KERATOMETERS

7.2.2.3 TONOMETERS

7.2.2.4 PHOROPTERS

7.2.2.5 RETINOSCOPES

7.2.2.6 OPHTHALMOSCOPES

7.2.2.7 SLIT LAMPS

7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS

7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

7.2.2.10 FUNDUS CAMERAS

7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

7.2.2.11.1 A- SCAN IMAGING SYSTEM

7.2.2.11.2 B-SCAN IMAGING SYSTEM

7.2.2.11.3 PACHYMETERS

7.2.2.11.4 ULTRASOUND BIOMICROSCOPES

7.2.2.12 LENSMETERS

7.2.2.13 WAVEFRONT ABERROMETERS

7.2.2.14 OPTICAL BIOMETRY SYSTEMS

7.2.2.15 SPECULAR MICROSCOPES

7.2.2.16 CHART PROJECTORS

7.2.3 OPHTHALMIC SURGICAL ACCESSORIES

7.2.3.1 SURGICAL INSTRUMENTS & KITS

7.2.3.2 OPHTHALMIC FORCEPS

7.2.3.3 OPHTHALMIC SPATULA

7.2.3.4 OPHTHALMIC TIPS AND HANDLES

7.2.3.5 OPHTHALMIC CANNULAS

7.2.3.6 OPHTHALMIC SCISSORS

7.2.3.7 OTHERS SURGICAL ACCESSORIES

7.2.4 OPHTHALMIC MICROSCOPES

7.3 DRUGS

7.3.1 ANTI-VEGF DRUGS

7.3.1.1 RANIBIZUMAB

7.3.1.2 BEVACIZUMAB

7.3.2 ANTI-GLAUCOMA DRUGS

7.3.2.1 PROSTAGLANDIN ANALOGS

7.3.2.1.1 LATANOPROST

7.3.2.1.2 BIMATOPROST

7.3.2.1.3 TRAVOPROST

7.3.2.1.4 TAFLUPROST

7.3.2.1.5 LATANOPROSTENE

7.3.2.2 BETA ADRENERGIC ANTAGONISTS

7.3.2.2.1 TIMOLAL MALEATE

7.3.2.2.2 BETAXOLOL

7.3.2.3 ALPHA ADRENERGIC AGONISTS

7.3.2.3.1 EPINEPHRINE

7.3.2.3.2 DEPIVEPRINE

7.3.2.4 MIOTICS

7.3.2.4.1 PILOCARPINE

7.3.2.4.2 ESERINE

7.3.3 ANTI-INFLAMMATION DRUGS

7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.4 RETINAL DISORDER DRUGS

7.3.5 DRY EYE DRUGS

7.3.6 ALLERGIC CONJUCTIVITIS DRUGS

7.3.7 OTHERS

7.3.7.1 BRANDED

7.3.7.2 GENERIC

7.3.7.3 PRESCRIPTION

7.3.7.4 OVER THE COUNTER

7.3.7.5 TOPICAL

7.3.7.6 LOCAL OCULAR

7.3.7.7 INJECTABLES

7.3.7.8 ORAL

7.3.7.9 OTHERS

7.3.7.10 EYE DROPS

7.3.7.11 EYE SOLUTION

7.3.7.12 CREAM & OINTMENTS

7.3.7.13 GEL

7.3.7.14 OTHERS

7.3.7.15 INTRAVITREAL

7.3.7.16 SUBCONJUNCTIVAL

7.3.7.17 RETROBULBAR

7.3.7.18 INTRACAMERAL

7.3.7.19 INTRAMUSCULAR

7.3.7.20 INTRAVENOUS

7.3.7.21 OTHERS

7.3.7.22 TABLET

7.3.7.23 CAPSULES

7.3.7.24 OTHERS

7.4 OTHERS

7.4.1 VISION CARE PRODUCTS

7.4.1.1 SPECTACLES

7.4.1.2 CONTACT LENSES

7.4.1.2.1 SOFT CONTACT LENSES

7.4.1.2.2 HYBRID CONTACT LENSES

7.4.1.2.3 RIGID GAS PERMEABLE LENSES

7.4.2 OTHERS

8 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES

8.1 OVERVIEW

8.2 CATARACT

8.3 REFRACTIVE DISORDERS

8.4 GLAUCOMA

8.5 AGE-RELATED MACULAR DEGENERATION

8.6 INFLAMMATORY DISEASES

8.7 OTHERS

9 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION

9.1 OVERVIEW

9.2 REFRACTION

9.2.1 AUTOMATED REFRACTOMETERS

9.2.2 SET OF TRIAL LENSES

9.2.3 CYCLOPLEGIC DRUGS

9.2.4 TRIAL FRAME

9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE

9.2.6 JACKSON CROSS CYLINDER

9.3 VISUAL ACUITY TEST

9.3.1 SNELLEN'S CHART

9.3.2 NEAR VISION CHARTS

9.4 INTRAOCULAR PRESSURE

9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)

9.4.2 OTHERS

9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION

9.5.1 SLIT LAMP BIOMICROSCOPE

9.5.2 TORCH LIGHT

9.6 VISUAL FIELDS TEST

9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER

9.6.2 FREQUENCY DOUBLING PERIMETER

9.6.3 GOLDMANN KINETIC PERIMETER

9.7 COLOR VISION TEST

9.8 OTHERS

10 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER

10.1 OVERVIEW

10.2 CLINICS

10.3 HOSPITALS

10.4 HOME HEALTHCARE

10.5 OTHERS

11 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL SHOPS

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

11.4 OTHERS

12 NORTH AMERICA OPHTHALMOLOGY MARKET BY GEOGRAPHY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ALCON

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 JOHNSON & JOHNSON SERVICES, INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ESSILOR LUXOTTICA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 NOVARTIS AG

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BAUSCH + LOMB

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 REVENUE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ABBVIE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BAYER AG

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 CARL ZEISS MEDITEC AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 COOPER COMPANIES

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.1 DOMPÉ

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 F. HOFFMANN-LA ROCHE LTD

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 GLAUKOS CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 HAAG-STREIT

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 HOYA CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 LUMENIS BE LTD.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 NIDEK CO.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 REICHERT, INC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 SANTEN PHARMACEUTICAL CO.

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 STAAR SURGICAL

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENT

15.2 TOPCON CORPORATION

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 ZIEMER OPHTHALMIC SYSTEMS AG

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 2 NORTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 3 NORTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 4 NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 5 NORTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 6 NORTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 7 NORTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 8 NORTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 9 NORTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 10 NORTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 11 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 12 NORTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 13 NORTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 14 NORTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 15 NORTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 16 NORTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 17 NORTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 18 NORTH AMERICA ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 19 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 20 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 21 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 22 NORTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 23 NORTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 24 NORTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 25 NORTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 27 NORTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 28 NORTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 29 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 30 NORTH AMERICA CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 31 NORTH AMERICA REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 32 NORTH AMERICA GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 33 NORTH AMERICA AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 34 NORTH AMERICA INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 36 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 37 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 38 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 39 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 40 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 41 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 42 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 43 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 44 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 45 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 46 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 47 NORTH AMERICA COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 48 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 49 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 50 NORTH AMERICA CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 51 NORTH AMERICA HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 52 NORTH AMERICA HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 53 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 54 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 55 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 56 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 57 NORTH AMERICA DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 58 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 59 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 60 NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 61 NORTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 62 NORTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 63 NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 64 NORTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 65 NORTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 66 NORTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 67 NORTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 68 NORTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 69 NORTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 70 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 71 NORTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 72 NORTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 73 NORTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 74 NORTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 75 NORTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 76 NORTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 77 NORTH AMERICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 78 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 79 NORTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 80 NORTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 81 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 82 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 83 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 84 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 NORTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 86 NORTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 87 NORTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 88 NORTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 89 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 90 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 91 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 92 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 93 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 94 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 95 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 96 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 97 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 98 U.S. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 99 U.S. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 100 U.S. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 101 U.S. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 102 U.S. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 103 U.S. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 104 U.S. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 105 U.S. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 106 U.S. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 107 U.S. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 108 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 109 U.S. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 110 U.S. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 111 U.S. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 112 U.S. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 113 U.S. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 114 U.S. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 115 U.S. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 116 U.S. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 117 U.S. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 118 U.S. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 119 U.S. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 120 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 121 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 122 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 123 U.S. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 124 U.S. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 U.S. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 126 U.S. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 127 U.S. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 128 U.S. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 129 U.S. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 130 U.S. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 131 U.S. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 132 U.S. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 133 U.S. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 134 U.S. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 135 U.S. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 136 CANADA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 137 CANADA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 138 CANADA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 139 CANADA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 140 CANADA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 141 CANADA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 142 CANADA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 143 CANADA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 144 CANADA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 145 CANADA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 146 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 147 CANADA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 148 CANADA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 149 CANADA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 150 CANADA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 151 CANADA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 152 CANADA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 153 CANADA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 154 CANADA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 155 CANADA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 156 CANADA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 157 CANADA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 158 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 159 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 160 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 161 CANADA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 162 CANADA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 163 CANADA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 164 CANADA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 CANADA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 166 CANADA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 167 CANADA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 168 CANADA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 169 CANADA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 170 CANADA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 171 CANADA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 172 CANADA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 173 CANADA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 174 MEXICO OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 175 MEXICO DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 176 MEXICO SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 177 MEXICO OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 178 MEXICO VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 179 MEXICO REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 180 MEXICO GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 181 MEXICO DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 182 MEXICO OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 183 MEXICO OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 184 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 185 MEXICO ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 186 MEXICO ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 187 MEXICO PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 188 MEXICO BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 189 MEXICO ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 190 MEXICO MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 191 MEXICO ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 192 MEXICO OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 193 MEXICO VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 194 MEXICO CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 195 MEXICO OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 196 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 197 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 198 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 199 MEXICO TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 200 MEXICO LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 201 MEXICO INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 202 MEXICO ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 203 MEXICO OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 204 MEXICO REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 205 MEXICO VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 206 MEXICO INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 207 MEXICO ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 208 MEXICO VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 209 MEXICO OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 210 MEXICO OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 211 MEXICO RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA OPHTHALMOLOGY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 NORTH AMERICA OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE NORTH AMERICA OPHTHALMOLOGY MARKET FROM 2025 TO 2032

FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA OPHTHALMOLOGY MARKET IN 2025 AND 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024

FIGURE 18 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)

FIGURE 19 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)

FIGURE 20 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 21 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, 2024

FIGURE 22 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)

FIGURE 23 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)

FIGURE 24 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 25 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024

FIGURE 26 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)

FIGURE 27 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)

FIGURE 28 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE

FIGURE 29 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, 2024

FIGURE 30 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)

FIGURE 31 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 32 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024

FIGURE 34 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)

FIGURE 35 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 36 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 NORTH AMERICA OPHTHALMOLOGY MARKET SNAPSHOT

FIGURE 38 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

Frequently Asked Questions

The market is segmented based on Segmentation, By Products (Device, Drugs, and Others), Diseases (Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others), Comprehensive Eye Examination (Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others), End User (Clinics, Hospitals, Home Healthcare, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends and Forecast to 2032 .
The North America Ophthalmology Market size was valued at USD 31.77 USD Billion in 2024.
The North America Ophthalmology Market is projected to grow at a CAGR of 6.5% during the forecast period of 2025 to 2032.